DV
Dividend Vision

SIBN — Si-Bone Inc

Si-Bone Inc (SIBN)

Total return is -5.6% over the past 7.8 years, 216.9 points behind SPY at 211.3%. Its deepest 1-year drawdown was 45.7%.

Si-Bone Inc is a medical device company that develops titanium implants and surgical instruments for bone fusion procedures, particularly for sacroiliac joint stabilization and spinal fusion applications; its product line includes the IFUSE series of implants along with related bone augmentation products, marketed primarily through a direct sales force. The company does not currently distribute dividends. Si-Bone appeals to growth-oriented equity investors seeking exposure to the orthopedic medical device sector rather than income investors.

SIBN key facts

Asset type
Stock
Asset class
Equity
Inception date
10/17/2018
Last close
$18.93
Market cap
$759,259,776
Average volume
206745.0
Beta
0.67
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.38